Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art.
- Published in:
- Cancer Communications, 2021, v. 41, n. 4, p. 287, doi. 10.1002/cac2.12153
- By:
- Publication type:
- Article
Works matching IS 2523-3548 AND VI 41 AND IP 4 AND DT 2021
Results: 8
1
2
The use of an oxidative stress scoring system in prognostic prediction for kidney renal clear cell carcinoma.
- Published in:
- Cancer Communications, 2021, v. 41, n. 4, p. 354, doi. 10.1002/cac2.12152
- By:
- Publication type:
- Article
3
An integrated genetic‐epigenetic analysis shed light on the mechanisms linking coronavirus disease 2019 (COVID‐19) and cancer.
- Published in:
- Cancer Communications, 2021, v. 41, n. 4, p. 349, doi. 10.1002/cac2.12151
- By:
- Publication type:
- Article
4
Individualized elective irradiation of the clinically node‐negative neck in definitive radiotherapy for head and neck squamous cell carcinoma.
- Published in:
- Cancer Communications, 2021, v. 41, n. 4, p. 303, doi. 10.1002/cac2.12145
- By:
- Publication type:
- Article
5
Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending.
- Published in:
- Cancer Communications, 2021, v. 41, n. 4, p. 345, doi. 10.1002/cac2.12144
- By:
- Publication type:
- Article
6
Junction plakoglobin regulates and destabilizes HIF2α to inhibit tumorigenesis of renal cell carcinoma.
- Published in:
- Cancer Communications, 2021, v. 41, n. 4, p. 316, doi. 10.1002/cac2.12142
- By:
- Publication type:
- Article
7
Pre‐transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors.
- Published in:
- Cancer Communications, 2021, v. 41, n. 4, p. 333, doi. 10.1002/cac2.12140
- By:
- Publication type:
- Article
8
Issue Information.
- Published in:
- Cancer Communications, 2021, v. 41, n. 4, p. 285, doi. 10.1002/cac2.12056
- Publication type:
- Article